BALA CYNWYD, Pa., March 6, 2015 /PRNewswire/ -- Law office of
Brodsky & Smith, LLC announces that it is investigating
potential claims against the Board of Directors of Pharmacylics,
Inc. ("Pharmacyclics" or "the Company") (Nasdaq-PCYC-News) for
possible breaches of fiduciary duty and other violations of state
law in connection with the sale of the Company to AbbVie, Inc.
("AbbVie")
Click here to learn more about the investigation
http://brodsky-smith.com/900-pcyc-pharmacyclics-inc.html, or call:
877-534-2590. There is no cost or obligation to you.
Under terms of the transaction, Pharmacyclics shareholders would
receive approximately $261.25 in a
combination of cash and AbbVie common stock for each share of
Pharmacyclics stock they own. The investigation concerns whether
the Board of Pharmacyclics breached their fiduciary duties to
stockholders by failing to adequately shop the Company before
agreeing to enter into this transaction, and whether AbbVie is
underpaying for Pharmacyclics. The transaction may undervalue
Pharmacyclics given that Imbruvica, its cancer fighting drug, may
be able to generate annual sales of $7
billion.
If you own shares of Pharmacyclics common stock and wish to
discuss the legal ramifications of the investigation, or have
any questions, you may e-mail or call the law office of
Brodsky & Smith, LLC who will, without obligation or cost to
you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith,
LLC, Two Bala Plaza, Suite 510, Bala
Cynwyd, PA 19004, by e-mail at
investorrelations@brodsky-smith.com, by visiting
http://brodsky-smith.com/900-pcyc-pharmacyclics-inc.html, or
calling toll free 877-LEGAL-90.
Brodsky & Smith, LLC is a litigation law firm with extensive
expertise representing shareholders throughout the nation in
securities and class action lawsuits. The attorneys at Brodsky
& Smith have been appointed by numerous courts throughout the
country to serve as lead counsel in class actions and have
successfully recovered millions of dollars for our clients and
shareholders. Attorney advertising. Prior results do not guarantee
a similar outcome.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/shareholder-alert-brodsky--smith-llc-announces-investigation-of-the-board-of-directors-of-pharmacyclics-inc---pcyc-300047011.html
SOURCE Brodsky & Smith, LLC